Exozymes Inc. (NASDAQ:EXOZ - Get Free Report)'s share price traded up 3.9% during mid-day trading on Tuesday . The stock traded as high as $13.99 and last traded at $13.96. 1,355 shares were traded during mid-day trading, a decline of 92% from the average session volume of 17,489 shares. The stock had previously closed at $13.44.
Exozymes Stock Down 2.6%
The stock's fifty day simple moving average is $12.68.
Exozymes (NASDAQ:EXOZ - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported ($0.22) EPS for the quarter.
Exozymes Company Profile
(
Get Free Report)
eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Read More
Before you consider eXoZymes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eXoZymes wasn't on the list.
While eXoZymes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
